Top VC Firms in Belgium

Focuses on growth and buyout capital for European energy transition scaleups and SMEs. They invest in companies that enable electrification and accelerate the energy transition, targeting grid enhancement, sustainable buildings, and industrial decarbonization.

Apheon is a pan-European mid-market private equity firm investing primarily in companies headquartered in the Benelux, France, Germany, Italy and Spain. It focuses on growth and transformation of companies through a partnership approach with management teams and families.

Transition Capital Partners is a European investment firm partnering with entrepreneurs and management teams to help build regional champions. They invest in small and medium enterprises across sectors including consumer goods, consumer services, connected industries, and business services, supporting growth, business transition, and operational improvements.

Fund+ invests in innovative life sciences companies primarily active in therapeutics, diagnostics, and medical devices, targeting companies seeking Series A or B financing with an established Proof of Concept. The fund focuses on Belgium and aims for both financial and societal returns.

Heran Partners is a specialist venture capital investor committed to creating transformative impact within the life sciences and healthcare industry. They invest at seed, Series A and Series B stage in healthcare and life sciences technology companies with strong clinical backbone and B2B business models.

Vesalius Biocapital III invests in innovative biotech and life sciences companies primarily in Europe, focusing on transformative therapies and technologies with strong growth potential in healthcare.

Invests in early-stage and growth startups across Europe and Silicon Valley. Focuses on data, AI, and robotics sectors.

Capricorn Partners invests venture and growth capital primarily in digital technologies, health and clean technologies, focusing on European companies with a special emphasis on the Benelux region.

GIMV invests in companies with a focus on healthcare and life sciences. They provide capital for growth and expansion, often participating in series B and later rounds.

Omega Funds invests in the future of medicine.

Invests in early- to mid-stage life science companies with high growth potential. Focuses on transformational innovations in biotech, pharmaceutical, and agricultural sectors.

Finindus provides early stage and growth financing (equity and debt) to innovative technology companies active in materials, sustainable manufacturing and Industry 4.0 sectors across Europe, focusing on Flanders and with global investments aligned with shareholder strategic interests.

imec.xpand invests in innovative, early-stage nanoelectronics-based ideas and projects, leveraging imec's expertise and infrastructure. It focuses on early-stage deep tech ventures, reserving capital for follow-on and growth financing to ensure superior returns.

Volta Ventures is a pre-seed and seed VC firm investing in B2B software startups in the Benelux region, with investments ranging between €100k and €1M.

Syndicate One invests early-stage capital out of a €22 million fund, focused on Belgian top founders and the tech startup ecosystem.

Hummingbird Ventures is a venture capital firm that invests in early-stage technology companies with global ambitions. They focus on disruptive technologies and scalable business models across various sectors.

Astanor Ventures is a venture capital firm that invests in startups that are transforming the food and agriculture industry. They focus on companies that are developing sustainable and regenerative solutions to improve the food system, from farm to table.

Innovation Industries focuses on early-stage investments in Belgium and the Netherlands. They primarily target companies in the Industry & Hardware sector, often participating in Series A rounds.

Qbic is a sector-agnostic seed and early-stage venture capital fund, supporting spin-offs and start-ups that valorize research from Qbic's knowledge partners. They typically participate in the first external investment round and continue to support companies throughout their growth.

Focuses on early-stage companies in Belgium. Primarily invests in the Healthcare & Life Sciences sector.

Focuses on companies in Belgium. Invests in the Commerce & Marketing and Healthcare & Life Sciences sectors, primarily in later stage companies.

Fortino Capital invests in early-stage B2B software companies in the Benelux and Germany. They focus on software and developer tools that drive digital transformation.

Invests in early-stage startups, demonstrated by participation in the $6m seed round of Belgian deeptech startup Belfort focused on novel chip technology for fully encrypted data processing.

VIB invests in early-stage life science and biotech startups and spin-offs, translating groundbreaking biomolecular research into tangible applications. They focus on projects addressing unmet medical needs or offering sustainable solutions for the environment and agriculture.